Analysis of the mechanism by which ketamine affects astrocytes in Parkinsonian rats through the PI3K/AKT axis.
Cellular and molecular biology (Noisy-le-Grand, France) May 27, 2024 Yanhong Xiong, Jianwen Yuan, Luogeng Xu 1 citation
Parkinson's disease (PD) remains the most common neurodegenerative disease worldwide, seriously affecting the normal life of patients. Currently, there is no effective clinical cure for PD. In this study, the research team explored the effect of ketamine (KET) on PD, which can lay a reliable foundation for future KET treatment of PD. First, the research team established a PD rat model with...
DOI: 10.14715/cmb/2024.70.5.29 (opens in new tab)
Full text (opens in new tab)
Parkinsons-disease
Ketamine-therapy
Brain-inflammation
Astrocytes